The influence of dietary supplementation with cranberry tablets on the urinary risk factors for nephrolithiasis

Purpose Cranberry supplements are commonly used as a natural deterrent to urinary tract infection. However, one small study ( n  = 5) which showed an increase in urinary oxalate levels following cranberry supplementation has led to its use with caution among patients susceptible to nephrolithiasis....

Full description

Saved in:
Bibliographic Details
Published inWorld journal of urology Vol. 37; no. 3; pp. 561 - 566
Main Authors Redmond, Elaine J., Murphy, C. F., Leonard, J., Faulds, K., Abdelfadil, S., Crowley, V. E., Lynch, T. H., Manecksha, R. P.
Format Journal Article
LanguageEnglish
Published Berlin/Heidelberg Springer Berlin Heidelberg 01.03.2019
Springer Nature B.V
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Purpose Cranberry supplements are commonly used as a natural deterrent to urinary tract infection. However, one small study ( n  = 5) which showed an increase in urinary oxalate levels following cranberry supplementation has led to its use with caution among patients susceptible to nephrolithiasis. Furthermore, most commonly available cranberry tablet preparations contain vitamin C, which has been independently shown to increase urinary oxalate excretion. The aim of this study is to investigate the influence of cranberry supplementation on urinary oxalate excretion. Methods Fifteen participants were randomised to receive cranberry tablets alone or cranberry tablets containing vitamin C. Tablets were taken at the manufacturers recommended dosage for a period of 14 days. Participants provided a 24 h urine collection at trial entry and day 14. Urinary variables were compared to assess for changes in oxalate levels. Results The median age was 27 years (21–43). There was no difference in the 24 h urine volume pre or post commencement of cranberry tablets (1.7 vs 2 L, p  = 0.07). An increase in median urinary oxalate excretion was observed in participants taking both cranberry-only tablets (0.10 mmol/day) and tablets containing vitamin C (1.15 mmol/day). Conclusion Dietary supplementation with cranberry increases urinary oxalate excretion and should be avoided in patients at risk of urolithiasis.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-News-1
ObjectType-Feature-3
content type line 23
ISSN:0724-4983
1433-8726
DOI:10.1007/s00345-018-2344-1